CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer
Authors
Keywords
Non-small cell lung cancer (NSCLC), Copine 1 (CPNE1), microRNA, miR-335-5p
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-03
DOI
10.1186/s13046-018-0811-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma
- (2017) Kefeng Wang et al. Molecular Cancer
- CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer
- (2017) Jianjie Zhu et al. Molecular Cancer
- CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer
- (2017) Jiabei Liang et al. MEDICAL SCIENCE MONITOR
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells
- (2016) Haibo Hu et al. LUNG CANCER
- Combinatorial Action of MicroRNAslet-7and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation
- (2015) Carlos Stahlhut et al. CELL CYCLE
- Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis
- (2015) Qing-yong Chen et al. Molecular BioSystems
- Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer
- (2015) JIANJIE ZHU et al. ONCOLOGY REPORTS
- Direct binding of Copine3 with Jab1 activates downstream ErbB2 signaling and motility in SKBr3 breast cancer cells
- (2015) HYE YOUNG CHOI et al. ONCOLOGY REPORTS
- Copine1 C2 domains have a critical calcium-independent role in the neuronal differentiation of hippocampal progenitor HiB5 cells
- (2014) Nammi Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis
- (2014) HAILONG LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non-Small Cell Lung Cancer
- (2013) J. Cai et al. CANCER RESEARCH
- Quantitative Proteomic Analysis Identifies CPNE3 as a Novel Metastasis-promoting Gene in NSCLC
- (2013) He-chun Lin et al. JOURNAL OF PROTEOME RESEARCH
- MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
- (2013) Bing Li et al. LUNG CANCER
- Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer
- (2012) Xiuling Zhi et al. IUBMB LIFE
- Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
- (2012) Vincent A Miller et al. LANCET ONCOLOGY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
- (2010) Federico Cappuzzo et al. LANCET ONCOLOGY
- Mammalian microRNAs predominantly act to decrease target mRNA levels
- (2010) Huili Guo et al. NATURE
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
- (2009) Danit Lebanony et al. JOURNAL OF CLINICAL ONCOLOGY
- Copine-III interacts with ErbB2 and promotes tumor cell migration
- (2009) C Heinrich et al. ONCOGENE
- Prognostic Value of Mature MicroRNA-21 and MicroRNA-205 Overexpression in Non-Small Cell Lung Cancer by Quantitative Real-Time RT-PCR
- (2008) A. Markou et al. CLINICAL CHEMISTRY
- Role ofKRASandEGFRAs Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
- (2008) Chang-Qi Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search